On June 20th MBBP client Medical Capital Advisors, LLC announced it had received the Healthcare/Life Sciences Deal of the Year award as part of the 2nd Annual ACG New York Champion’s Awards. MedCap Advisors was recognized for its work in connection with the Joint Development and Distribution Agreement between Musculoskeletal Transplant Foundation (MTF) and CONMED Corporation (NASDAQ:CNMD). The M&A Advisor and ACG started the Champion’s Awards to recognize companies, individual dealmakers and transactions in the middle market merger and acquisitions industry. Christopher Velis, the CEO of Medical Capital Advisors had this to say of the honor:
This award is a remarkable honor that also highlights the groundbreaking nature of the MTF agreement and the growing importance of biologics in the medical technology field. Our entire team would like to thank ACG New York and The M&A Advisor for selecting us among the many esteemed finalists.
Congratulations MedCap Advisors!
To learn more about the awards or to see the full list of recipients, please visit the M&A Advisor.